C Vlachopoulos, D Terentes-Printzios, N … - Current Pharmaceutical Design, 2009 - ingentaconnect.com Abstract: Phosphodiesterase type-5 (PDE5) inhibitors are widely used as
first-line therapy for erectile dysfunction (ED). Their efficacy and safety
combined with an increasing understanding of cyclic guanosine monophosphate ... Cited by 2 - Related articles